Differences in the potencies of inhaled steroids are not reflected in the doses prescribed in primary care in New Zealand

European Journal of Clinical Pharmacology

Volumn 56, Issue 5, 2000, Pages 431-435

  Black, P N ^a   Lawrence, B J ^a   Goh, K H ^b   Barry, M S ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b ProCare Health Limited   (New Zealand)

Author keywords

Inhaled corticosteroids; Potency; Prescription analysis

Indexed keywords

BECLOMETASONE; BUDESONIDE; CROMOGLYCATE DISODIUM; FLUTICASONE;

ARTICLE; ASTHMA; DRUG POTENCY; DRUG UTILIZATION; GENERAL PRACTITIONER; HUMAN; METERED DOSE INHALER; NEW ZEALAND; PHARMACOEPIDEMIOLOGY; POWDER INHALER; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

EID: 0033844214     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000140     Document Type: Article

References (21)

1. Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: Retrospective study of computerised general practice records
2. Patients do not take the prescribed dose
3. Back titration of inhaled steroids is uncommon in New Zealand
4. Study was inadequate
5. Studies of potencies of asthma drugs have methodological limitations
6. A comparison of beclomethasone dipropionate and budesonide in the treatment of asthma
7. Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma
8. Clinical efficacy of budesonide Turbuhaler compared with budesonide propionate pMDI with volumatic spacer
9. A 1-year comparison of turbuhaler vs pressurized metered dose-inhaler in asthmatic subjects
10. A 3-month comparative dose-reduction study with inhaled beclomethasone dipropionate and budesonide in the management of moderate to severe asthma
11. A comparison of fluticasone propionate 200 mcg/day with beclomethasone dipropionate 400 mcg/day in adult asthma
12. -1) administered by pressurized inhaler
13. A comparison of fluticasone, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma
14. A blinded comparison of fiuticasone propionate with budesonide via powder devices in adult patients with moderate-to-severe asthma: A clinical evaluation
15. Fluticasone propionate 200 mcg daily versus beclomethasone dipropionate 400 mcg daily in children with mild to moderate asthma
16. Fluticasone propionate 1 mg daily versus beclomethasone dipropionate 2 mg daily for 1 year in severe asthma
17. Clinical experience with fluticasone propionate in asthma: A meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less
18. The psychological factors associated with poor compliance in the treatment in asthma
19. Comparison of addition of salmeterol to inhaled steroids with the doubling of the dose of inhaled steroids
20. Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids
21. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients